| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |